This compound is a pharmaceutical intermediate used in the manufacturing process of iguratimod. It features a tetracyclic ring system with hydroxyl and ester functional groups.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1206124-13-1
Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate
pharmaceutical intermediate
N-(5-(4-formylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
Pharmaceutical intermediate for Filgotinib synthesis
N-(5-(4-(bromomethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide
Filgotinib intermediate
(5-Bromo-3-(trifluoromethyl)pyridin-2-yl)methanol
pharmaceutical intermediate
Etrasimod Impurity 42
Pharmaceutical intermediate for etrasimod
1,2,3,4-Tetrahydro-7-methoxycyclopent[b]indole-3-acetic acid
n.a
ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate
QPXXHQCMPZUYDB-UHFFFAOYSA-N
CCOC(=O)CC1CCC2=C1NC3=C2C=C(C=C3)O